Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone

Bone

Volumn 24, Issue 6, 1999, Pages 541-547

  Musgrave, D S ^a   Bosch, P ^a   Ghivizzani, S ^b   Robbins, P D ^b   Evans, C H ^a   Huard, J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenovirus; Bone; Bone morphogenetic protein (BMP); Direct gene transfer; Gene therapy; Skeletal muscle

Indexed keywords

BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN; RECOMBINANT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FRACTURE HEALING; GENE THERAPY; GENE TRANSFER; HISTOLOGY; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSSIFICATION; SKELETAL MUSCLE;

ADENOVIRIDAE; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOCOMPETENCE; INJECTIONS, INTRAMUSCULAR; LAC OPERON; MICE; MICE, INBRED C57BL; MICE, SCID; OSTEOGENESIS; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032904745     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00086-1     Document Type: Article

References (43)

1. Ascadi G., Jani A., Massie B., Simoneau M., Holland P., Blaschuk K., Karpati G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Molec Genet. 3:1994;579-584.
2. Balk M.L., Bray J., Day C., Epperly M., Greenberger J., Evans C.H., Niyibizi C. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim). Bone. 21:1997;7-15.
3. Bosch, P., Musgrave, D. S., Shuler, F., Ghivizzani, S. C., Evans, C., Robbins, P. D., and Huard, J. Bone formation from muscle derived cells. J. Orthop Res, to be published.
4. Bostrom M., Lane J.M., Tomin E., Browne M., Berberain W.S., Turek T., Smith J., Wozney J., Schildhauer T. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop. 327:1996;272-282.
5. Caplan A.I. Mesenchymal stem cells. J Orthop Res. 9:1991;641-650.
6. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C., Whitecloud T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Jt Surg. 76-A:1994;827-838.
7. Cook S.D., Wolfe M.W., Salkeld S.L., Rueger D.C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Jt Surg. 77-A:1995;734-750.
8. Fang J., Zhu Y.-Y., Smiley E., Bonadio J., Rouleau J.P., Goldstein S.A., McCauley L.K., Davidson B.L., Roessler B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci. 93:1996;5753-5758.
9. Guha S.C., Poole M.D. Stress fracture of the iliac bone with subfacial femoral neuropathy Unusual complication at a bone graft donor site: Case report . Br J Plast Surg. 36:1983;305-306.
10. Hardy S., Kitamura M., Harris-Stansil T., Yumin D., Phipps M.L. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 71:1997;1842-1849.
11. Heckman J.D., Boyan B.D., Aufdemorte T.B., Abbott J.T. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Jt Surg. 73-A:1991;750-764.
12. Johnson E.E., Urist M.R., Finerman G.A.M. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions A preliminary report . Clin Orthop. 230:1988;257-265.
13. Johnson E.E., Urist M.R., Finerman G.A.M. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein A preliminary report . Clin Orthop. 236:1988;249-257.
14. Johnson E.E., Urist M.R., Finerman G.A.M. Distal metaphyseal tibial nonunion Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP) . Clin Orthop. 250:1990;234-240.
15. Khouri R.K., Brown D.M., Koudsi B., Deune E.G., Gilula L.A., Cooley B.C., Reddi A.H. Repair of calvarial defects with flap tissue Role of bone morphogenetic proteins and competent responding tissues . Plast Reconstr Surg. 98:1996;103-109.
16. Kirker-Head C.A., Gerhart T.N., Armstrong R., Schelling S.H., Carmel L.A. Healing bone using recombinant human bone morphogenetic protein-2 and copolymer. Clin Orthop. 349:1998;205-217.
17. Lieberman J.R., Kono M., Vertelney E., Finerman G.A.M., Witte O.N. The creation of a rhBMP-2 producing cell line Retroviral gene transfer of rhBMP-2 into a stromal line (S17) . Trans Orthop Res Soc 41st Ann Meeting. 20:1995;499.
18. Lieberman J.R., Le L.Q., Wu L., Finerman G.A.M., Berk A., Witte O.N., Stevenson S. Regional gene therapy with a BMP-2 producing stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res. 16:1998;330-339.
19. Lindholm T.C., Lindholm T.S., Alitalo I., Urist M.R. Bovine bone morphogenetic protein (bBMP) induced repair of skull trephine defects in sheep. Clin Orthop. 227:1988;265-268.
20. Marden L.J., Hollinger J.O., Chaudhari A., Turek T., Schaub R.G., Ron E. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res. 28:1994;1127-1138.
21. Miyazawa K., Urist M.R. Treatment with recombinant human macrophage colony-stimulating factor resorbs blood clot and restores osteoclastogenesis in heterotopic bone induced by partially purified native bone morphogenetic protein in osteopetrotic (op/op) mice. J Orthop Res. 15:1997;456-462.
22. Musgrave, D. S., Bosch, P., Ghivizzani, S., Robbins, P. D., and Huard, J. The importance of cell identity in ex vivo gene therapy to produce bone. Manuscript in preparation.
23. Nilsson O.S., Urist M.R., Dawson E.G., Schamlzreid T.P., Finerman G.A.M. Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. J Bone Jt Surg. 68-B:1986;635-642.
24. Reid E.L. Hernia through an iliac bone graft donor site A case report . J Bone Jt Surg. 50-A:1968;757-760.
25. Ripamonti U., Ma S.S., Cunningham N.S., Yeates L., Reddi A.H. Reconstruction of the bone-bone marrow organ by osteogenin, a bone morphogenetic protein, and demineralized bone matrix in calvarial defects in adult primates. Plast Reconstr Surg. 91:1993;27-36.
26. Ripamonti U., Ma S.S., Reddi A.H. Induction of bone in composites of osteogenin and porous hydroxyapatite in baboons. Plast Reconstr Surg. 89:1992;731-739.
27. Robbins P.D., Ghivizzani S.C. Viral vectors for gene therapy. Pharmacol Ther. 80:1998;35-47.
28. Sanes J.R., Rubenstein J.L.R., Nicolas J.F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. Eur Mol Biol Org J. 5:1986;5133-5142.
29. Shafritz A.B., Shore E.M., Gannon F.H., Zasloff M.A., Taub R., Muenke M., Kaplan F.S. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 335:1996;555-593.
30. Stevenson S., Cunningham N., Toth J., Davy D., Reddi A.H. The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. J Bone Jt Surg. 76-A:1994;1676-1687.
31. Summers B.N., Eisenstein S.M. Donor site pain from the ilium A complication of lumbar spine fusion . J Bone Jt Surg. 71-B:1989;677-680.
32. Urist M.R. Bone Formation by autoinduction . Science. 150:1965;893-899.
33. Urist M.R., Hay P.H., Dubuc F., Buring K. Osteogenic competence. Clin Orthop. 64:1969;194-220.
34. Urist M.R., Nakagawa M., Nakata N. Experimental myositis ossificans. Arch Pathol Lab Med. 102:1978;312-316.
35. van Deutekom J.C.T., Floyd S.S., Booth D.K., Oligino T., Krisky D., Marconi P., Glorioso J.C., Huard J. Implications of maturation for viral gene delivery to skeletal muscle. Neuromusc Disord. 8:1998;135-148.
36. Wang E.A., Rosen V., D'Assandro J.S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA. 87:1990;2220-2224.
37. Weikel A.M., Habal M.B. Meralgia paresthetica A complication of iliac bone procurement . Plast Reconstr Surg. 60:1977;572-574.
38. Yamaguchi A., Katagari T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., Yoshika S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol. 113:1991;681-687.
39. Yamazaki Y., Oida S., Ishihara K., Nakabayashi N. Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymeric reservoir. J Biomed Mater Res. 30:1996;1-4.
40. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., Wang E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Jt Surg. 74-A:1992;659-670.
41. Yoshikawa H., Rettig W.J., Takaoka K., Alderman E., Rup B., Rosen V., Wozney J.M., Lane J.M., Huvos A.G., Garin-Chesa P. Expression of bone morphogenetic proteins in human osteosarcoma Immunohistochemical detection with monoclonal antibody . Cancer. 73:1994;85-91.
42. Zegzula H.D., Buck D.C., Brekke J., Wozney J.M., Hollinger J.O. Bone formation with use of rhBMP-2. J Bone Jt Surg. 79-A:1997;1778-1790.
43. Zellin G., Linde A. Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2 An experimental study in rabbits . Scand J Plast Reconstr Hand Surg. 31:1997;97-104.